Background Three months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics, capability to detect and monitor COVID-19, and disease control measures in these 24 countries, 2) understand potential factors for the reported delayed COVID-19 introduction, and 3) identify gaps and opportunities for outbreak preparedness, particularly in low and middle-income countries (LMICs). We collected and analyzed publicly available information on country characteristics, COVID-19 testing, influenza surveillance, border measures, and preparedness activities in these countries. We also assessed the association between the temporal spread of COVID-19 in all countries with reported cases with globalization indicator and geographic location. Results Temporal spreading of COVID-19 was strongly associated with countries’ globalization indicator and geographic location. Most of the 24 countries with delayed COVID-19 introduction were LMICs; 88% were small island or landlocked developing countries. As of 30 March 2020, only 38% of these countries reported in-country COVID-19 testing capability, and 71% reported conducting influenza surveillance during the past year. All had implemented two or more border measures, (e.g., travel restrictions and border closures) and multiple preparedness activities (e.g., national preparedness plans and school closing). Conclusions Limited testing capacity suggests that most of the 24 delayed countries may have lacked the capability to detect and identify cases early through sentinel and case-based surveillance. Low global connectedness, geographic isolation, and border measures were common among these countries and may have contributed to the delayed introduction of COVID-19 into these countries. This paper contributes to identifying opportunities for pandemic preparedness, such as increasing disease detection, surveillance, and international collaborations. As the global situation continues to evolve, it is essential for countries to improve and prioritize their capacities to rapidly prevent, detect, and respond, not only for COVID-19, but also for future outbreaks.
Objective: The objectives of this study are to (1) create a mental health syndrome definition for syndromic surveillance to monitor mental health-related ED visits in near real time; (2) examine whether CC data alone can accurately detect mental health related ED visits; and (3) assess the added value of using Dx data to detect mental health-related ED visits.Introduction: Between 2006 and 2013, the rate of emergency department (ED) visits related to mental and substance use disorders increased substantially. This increase was higher for mental disorders visits (55 percent for depression, anxiety or stress reactions and 52 percent for psychoses or bipolar disorders) than for substance use disorders (37 percent) visits [1]. This increasing number of ED visits by patients with mental disorders indicates a growing burden on the health-care delivery system. New methods of surveillance are needed to identify and understand these changing trends in ED utilization and affected underlying populations.Syndromic surveillance can be leveraged to monitor mental health-related ED visits in near real-time. ED syndromic surveillance systems primarily rely on patient chief complaints (CC) to monitor and detect health events. Some studies suggest that the use of ED discharge diagnoses data (Dx), in addition to or instead of CC, may improve sensitivity and specificity of case identification [2].Methods: We extracted a de-identified random sample of 50,000 ED visits with CC from the National Syndromic Surveillance Program (NSSP) for the period January 1—June 30, 2017. NSSP’s BioSense Platform receives ED data from >4000 hospitals, representing about 55 percent of all ED visits in the country [3]. From this sample we extracted 22868 ED visits that included both CC and Dx data. We then applied our mental health syndrome case definition which comprised mental health-related keywords and ICD-9-CM and ICD-10-CM codes. We queried CC text for the words “stress,” “PTSD,” “anxiety,” “depression,” “clinical depression,” “manic depression,” “unipolar depression,” “agitated,” “nervousness,” “mental health,” “mental disorder,” “affective disorder,” “schizoaffective disorder,” “psycoaffective disorder,” “obsessive-compulsive disorder,” “mood disorder,” “bipolar disorder,” “schizotypal personality disorder,” “panic disorder,” “psychosis,” “paranoia,” “psych,” “manic,” “mania,” “hallucinating,” “hallucination,” “mental episode,” and “mental illness.” We queried Dx fields either for ICD-9- CM codes 295-296; 300, 311 or for ICD-10-CM codes F20-F48. The ICD-9- CM and ICD-10-CM codes used to identify mental health-related ED visits are based on the mental health disorders most frequently seen in EDs. Alcohol and substance use, suicide ideation, and suicide attempt were excluded from this study because they are included in alternate syndromes [2]. We manually reviewed the CC text to validate the search terms. Sensitivity, specificity, and positive predictive value will be calculated based on agreement of coding mental health against the human review of mental health visits.Based on our case definition, the sample of 22868 ED visits with CC and Dx data was further stratified into two groups: (1) mental health identified in either CC or Dx, and (2) no mental health identified in CC and Dx. Group 1 was further stratified into three groups: (a) mental health identified only in CC, (b) mental health identified in both CC and Dx, and (c) mental health identified only in Dx. The sample of 27132 ED visits with CC and no Dx data was further stratified into two groups: (1) mental health identified in CC, and (2) no mental health identified in CC (Figure).Results: Of the 50,000 sample of ED visits with CC data, 22868 visits had both CC and Dx data. Of the 22868 visits, we identified 1560 mental health-related ED visits using the mental health syndrome case definition. Of those visits, 241 were identified by a CC only, 226 were identified by both CC and Dx, and 1093 by a mental health-related Dx. Of the 27132 ED visits without Dx data, 421 had mental health identified in CC.Conclusions: Based on our preliminary analysis these findings suggest potential benefits of including Dx data in syndrome binning for mental health. Mental health terms are more likely to be found in Dx data than in the CC (1093 vs. 662). Using CC alone may underestimate the number of mental health-related ED visits. This study had several limitations. Not all facilities reporting to NSSP provide chief complaint data in the same manner, some provide CC as a drop down menu with predefined terms while others include the full text of CC. Not all records contained a Dx code which limited our ability to examine the added value of Dx code for that subset.
ObjectiveReview the impact of applying regular data quality checks to assess completeness of core data elements that support syndromic surveillance.IntroductionThe National Syndromic Surveillance Program (NSSP) is a community focused collaboration among federal, state, and local public health agencies and partners for timely exchange of syndromic data. These data, captured in nearly real time, are intended to improve the nation's situational awareness and responsiveness to hazardous events and disease outbreaks. During CDC’s previous implementation of a syndromic surveillance system (BioSense 2), there was a reported lack of transparency and sharing of information on the data processing applied to data feeds, encumbering the identification and resolution of data quality issues. The BioSense Governance Group Data Quality Workgroup paved the way to rethink surveillance data flow and quality. Their work and collaboration with state and local partners led to NSSP redesigning the program’s data flow. The new data flow provided a ripe opportunity for NSSP analysts to study the data landscape (e.g., capturing of HL7 messages and core data elements), assess end-to-end data flow, and make adjustments to ensure all data being reported were processed, stored, and made accessible to the user community. In addition, NSSP extensively documented the new data flow, providing the transparency the community needed to better understand the disposition of facility data. Even with a new and improved data flow, data quality issues that were issues in the past, but went unreported, remained issues in the new data. However, these issues were now identified. The newly designed data flow provided opportunities to report and act on issues found in the data unlike previous versions. Therefore, an important component of the NSSP data flow was the implementation of regularly scheduled standard data quality checks, and release of standard data quality reports summarizing data quality findings.MethodsNSSP data was assessed for the national-level completeness of chief complaint and discharge diagnosis data. Completeness is the rate of non- null values (Batini et al., 2009). It was defined as the percent of visits (e.g., emergency department, urgent care center) with a non-null value found among the one or more records associated with the visit. National completeness rates for visits in 2016 were compared with completeness rates of visits in 2017 (a partial year including visits through August 2017). In addition, facility-level progress was quantified after scoring each facility based on the percent completeness change between 2016 and 2017. Legacy data processed prior to introducing the new NSSP data flow were not included in this assessment.ResultsNationally, the percent completeness of chief complaint for visits in 2016 was 82.06% (N=58,192,721), and the percent completeness of chief complaint for visits in 2017 was 87.15% (N=80,603,991). Of the 2,646 facilities that sent visits data in 2016 and 2017, 114 (4.31%) facilities showed an increase of at least 10% in chief complaint completeness in 2017 compared with 2016. As for discharge diagnosis, national results showed the percent completeness of discharge diagnosis for 2016 visits was 50.83% (N=36,048,334), and the percent completeness of discharge diagnosis for 2017 was 59.23% (N=54,776,310). Of the 2,646 facilities that sent data for visits in 2016 and 2017, 306 (11.56%) facilities showed more than a 10% increase in percent completeness of discharge diagnosis in 2017 compared with 2016.ConclusionsNationally, the percent completeness of chief complaint for visits in 2016 was 82.06% (N=58,192,721), and the percent completeness of chief complaint for visits in 2017 was 87.15% (N=80,603,991). Of the 2,646 facilities that sent visits data in 2016 and 2017, 114 (4.31%) facilities showed an increase of at least 10% in chief complaint completeness in 2017 compared with 2016. As for discharge diagnosis, national results showed the percent completeness of discharge diagnosis for 2016 visits was 50.83% (N=36,048,334), and the percent completeness of discharge diagnosis for 2017 was 59.23% (N=54,776,310). Of the 2,646 facilities that sent data for visits in 2016 and 2017, 306 (11.56%) facilities showed more than a 10% increase in percent completeness of discharge diagnosis in 2017 compared with 2016.ReferencesBatini, C., Cappiello. C., Francalanci, C. and Maurino, A. (2009) Methodologies for data quality assessment and improvement. ACM Comput. Surv., 41(3). 1-52.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.